PULSE BIOSCIENCES, INC. — Form 8-K

Pulse Biosciences announced a partnership with the Clayman Thyroid Center (Hospital for Endocrine Surgery, Tampa, Florida) covering commercial deployment of the nPulse Vybrance System for benign thyroid nodule treatment and clinical collaboration to generate real-world outcomes data. No financial terms, payment amounts, or equity stakes are disclosed. The center is described as one of the largest thyroid surgery centers with significant regional and national referral patterns and will serve as the only site in the Tampa Bay Area offering nPulse technology for this indication.